Position in AZN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$6,528,426
-$1,686,970 QoQ
Shares Held
34,429
-17.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#354
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RITHOLTZ WEALTH MANAGEMENT holds $147,518,356 across 14 Drug Manufacturers - General names. AZN ranks #8 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,420 | $26,891,222 | |
| 2 | JNJ |
Johnson & Johnson
|
101,232 | $25,709,891 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
135,292 | $17,092,791 | |
| 4 | NVS |
Novartis AG
|
105,819 | $16,583,953 | |
| 5 | ABBV |
AbbVie Inc.
|
49,487 | $12,452,908 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
169,475 | $9,765,149 | |
| 7 | BIIB |
Biogen Inc.
|
34,283 | $7,407,184 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
34,429 | $6,528,426 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,528,426 | 34,429 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $8,215,396 | 41,656 | Shares | Sole | 2026-04-20 | |
| No filing history on record for this holder in this stock. | ||||||